TMQ Trilogy Metals Inc.
Gold and Silver Ores · NYSE · SEC CIK 1543418 · Fiscal year ends 11/30
Financial factors as of 2026-08-31 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-421.2%
TTM EPS YoY-383.3%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-39.0%
ROA-35.5%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets17.0%
Debt / equity0.00x
Current ratio1.33x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.11x
Accruals ratio-31.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-08-31 | 2026Q22026-05-31 | 2026Q12026-02-28 | 2025Q4*2025-11-30 | 2025Q32025-08-31 | 2025Q22025-05-31 | 2025Q12025-02-28 | 2024Q4*2024-11-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | — |
| SG&A expense | $294,000 | $430,000 | $567,000 | $420,000 | $214,000 | $353,000 | $343,000 | $191,000 |
| Net income | $244,000 | -$6.34M | -$7.06M | -$34.69M | -$1.75M | -$2.18M | -$3.62M | -$1.64M |
| EPS (basic) | 0.00 | -0.04 | -0.04 | — | -0.01 | -0.01 | -0.02 | — |
| EPS (diluted) | 0.00 | -0.04 | -0.04 | — | -0.01 | -0.01 | -0.02 | — |
| Weighted avg. shares (diluted) | 172.76M | 172.61M | 171.94M | — | 164.26M | 164.20M | 162.83M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $31.21M | $38.84M | $47.78M | $51.61M | $23.37M | $24.62M | $25.21M | $25.83M |
| Receivables | $93,000 | $106,000 | $112,000 | $118,000 | $17,000 | $20,000 | $19,000 | $16,000 |
| Current assets | $31.64M | $39.01M | $48.02M | $51.92M | $23.73M | $24.70M | $25.33M | $26.05M |
| Total assets | $140.75M | $151.19M | $154.54M | $157.30M | $129.12M | $130.98M | $132.39M | $133.70M |
| Current liabilities | $23.88M | $35.22M | $33.00M | $33.11M | $373,000 | $874,000 | $702,000 | $793,000 |
| Total liabilities | $23.91M | $35.27M | $33.06M | $33.18M | $455,000 | $967,000 | $800,000 | $903,000 |
| Shareholders' equity | $116.84M | $115.92M | $121.48M | $124.12M | $128.66M | $130.02M | $131.59M | $132.79M |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.11M | -$1.04M | -$2.74M | -$558,000 | -$1.26M | -$677,000 | -$748,000 | $26,000 |
| Investing cash flow | -$6.50M | -$8.00M | -$2.50M | — | — | — | — | $0 |
| Financing cash flow | $0 | $110,000 | $1.33M | $29.79M | $22,000 | $71,000 | $131,000 | — |
| Depreciation & amortization | — | — | — | — | — | — | — | $0 |
| Stock-based compensation | -$675,000 | -$674,000 | -$3.10M | -$6.31M | -$374,000 | -$512,000 | -$2.26M | -$6.53M |
Free plan shows the latest 8 periods; Pro shows all 59 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.